Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

X.aa

Subclinical ANA positivity

Publications

Bloomquist JN, Laddu A, Engler R

Adverse effects of acebutolol in chronic stable angina: drug-induced positive antinuclear antibody.

Journal of cardiovascular pharmacology 1984 Sep-Oct;6;735-8 — 1984 Sep-Oct — 735-8

Booth RJ, Wilson JD, Bullock JY

Beta-adrenergic-receptor blockers and antinuclear antibodies in hypertension.

Clinical pharmacology and therapeutics 1982 May;31;555-8 — 1982 May — 555-8

Booth RJ, Bullock JY, Wilson JD

Antinuclear antibodies in patients on acebutolol.

British journal of clinical pharmacology 1980 May;9;515-7 — 1980 May — 515-7